What's in Allecra's pipeline?

Allecra has 6 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 4 in Phase 1.

Which companies overlap with Allecra's portfolio?

Top competitors by shared drug class: Qilu Hospital of Shandong University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/allecra.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Allecra — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allecra pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
cefepime/AAI101 combination	cefepime/AAI101 combination	phase 3	beta-lactam antibiotic	bacterial cell wall synthesis	Infectious Diseases

Therapeutic area mix

Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Qilu Hospital of Shandong University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Allecra:

Cite this brief

Drug Landscape (2026). Allecra — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/allecra. Accessed 2026-05-17.